Ackman Launches Allergan Proxy Fight Amid $53B Buyout Play
Activist investor Bill Ackman on Monday outlined plans to oust a majority of directors at Allergan Inc., his latest move to push the Botox maker into negotiations over a proposed $53.3...To view the full article, register now.
Already a subscriber? Click here to view full article